You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 5, 2024

PATIROMER SORBITEX CALCIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for patiromer sorbitex calcium and what is the scope of patent protection?

Patiromer sorbitex calcium is the generic ingredient in one branded drug marketed by Vifor Pharma and is included in one NDA. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Patiromer sorbitex calcium has one hundred and ninety-eight patent family members in twenty-seven countries.

One supplier is listed for this compound.

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for PATIROMER SORBITEX CALCIUM
Generic Entry Date for PATIROMER SORBITEX CALCIUM*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for PATIROMER SORBITEX CALCIUM
Drug ClassPotassium Binder
Mechanism of ActionPotassium Ion Binding Activity
Paragraph IV (Patent) Challenges for PATIROMER SORBITEX CALCIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VELTASSA for Oral Suspension patiromer sorbitex calcium 8.4 g, 16.8 g and 25.2 g 205739 2 2019-10-21

US Patents and Regulatory Information for PATIROMER SORBITEX CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-002 Oct 21, 2015 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-003 Oct 21, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-002 Oct 21, 2015 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-002 Oct 21, 2015 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-002 Oct 21, 2015 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-003 Oct 21, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Vifor Pharma VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-001 Oct 21, 2015 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PATIROMER SORBITEX CALCIUM

International Patents for PATIROMER SORBITEX CALCIUM

Country Patent Number Title Estimated Expiration
South Korea 101199608 ⤷  Try a Trial
Poland 3219312 ⤷  Try a Trial
Canada 2806465 POLYMERES DE LIAISON IONIQUE ET LEURS UTILISATIONS (ION BINDING POLYMERS AND USES THEREOF) ⤷  Try a Trial
Germany 112005000730 Ionen bindende Polymere und ihre Verwendung ⤷  Try a Trial
Japan 2012500806 ⤷  Try a Trial
Japan 2020176155 高血圧症及び高カリウム血症を治療するためのカリウム結合剤 (POTASSIUM BINDER FOR TREATING HYPERTENSION AND HYPERKALEMIA) ⤷  Try a Trial
Lithuania PA2018016 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PATIROMER SORBITEX CALCIUM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2957286 CR 2018 00043 Denmark ⤷  Try a Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721
2957286 C20190015 00286 Estonia ⤷  Try a Trial PRODUCT NAME: KALTSIUMPATIROMEER;REG NO/DATE: EU/1/17/1179 21.07.2017
2365988 122018000012 Germany ⤷  Try a Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719
2957286 LUC00094 Luxembourg ⤷  Try a Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
2957286 6/2019 Austria ⤷  Try a Trial PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721
1732523 300925 Netherlands ⤷  Try a Trial PRODUCT NAME: PATIROMER EN ALLE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/17/1179/001-009 20170721
2957286 404 50019-2018 Slovakia ⤷  Try a Trial PRODUCT NAME: PATIROMER SORBITEX KALCIUM; REGISTRATION NO/DATE: EU/1/17/1179/001 - EU/1/17/1179/009 20170721
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.